CoChat

DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Following DNA damage caused by exogenous sources, such as ionizing radiation, the tumour suppressor p53 mediates cell cycle arrest via expression of the CDK inhibitor, p21. However, the role of p21 in maintaining genomic stability in the absence of exogenous DNA-damaging agents is unclear. Here, using live single-cell measurements of p21 protein in proliferating cultures, we show that naturally occurring DNA damage incurred over S-phase causes p53-dependent accumulation of p21 during mother G2- and daughter G1-phases. High p21 levels mediate G1 arrest via CDK inhibition, yet lower levels have no impact on G1 progression, and the ubiquitin ligases CRL4 Cdt2 and SCF Skp2 couple to degrade p21 prior to the G1/S transition. Mathematical modelling reveals that a bistable switch, created by CRL4 Cdt2 , promotes irreversible S-phase entry by keeping p21 levels low, preventing premature S-phase exit upon DNA damage. Thus, we characterize how p21 regulates the proliferation-quiescence decision to maintain genomic stability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms14728

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cells exhibit cell-to-cell variability in p21 expression. (a) Image of p21-GFP (magenta) and mRuby-PCNA (turquoise) expressing hTert-RPE1 cells. Scale bar is 10 μm. (b) Cell features captured by automated image analysis (Methods) from a single cell expressing mRuby-PCNA and p21-GFP. (c) Single-cell traces of p21-GFP levels aligned to S/G2; n=51 cells. Tracks are coloured according to p21-GFP intensity. Black circles represent mitosis. (d) Correlation between maximum G1 p21-GFP intensity and G1 length (Pearson's Correlation R=0.62** (P<0.01)). Three different 488 nm exposures are shown: Exp1, n=206 cells; Exp2, n=90; Exp3, n=52 (Methods). (e) Correlation in G1 p21-GFP levels between sister cells—G1 Daughter1 (G1D1) and G1 Daughter2 (G1D2; n=62, Pearson's Correlation R=0.81** (P<0.01)). Data points are coloured to represent correlation between G1 length in each daughter cell, calculated as the difference between the maximum and minimum G1 length divided by the sum of the sister G1 lengths, n=62. (f) Single-cell traces of p21-GFP levels aligned to mitotic exit; n=51 cells. Grey line marks 600 min time point used to define G1pm arrest. Red curves are cells that enter a G1pm arrest, blue curves are cells that enter S-phase (cycle). (g) Mean p21-GFP intensity in G2M separated by daughter cell fate: cycling, n=49 cells; single arrest, n=9; twin arrest, n=10. Significant differences are observed between arrested and cycling states using a two-sample t-test on log-transformed data. Error bar is s.d. *P<0.05, **P<0.01.
Figure 1 Cells exhibit cell-to-cell variability in p21 expression. (a) Image of p21-GFP (magenta) and mRuby-PCNA (turquoise) expressing hTert-RPE1 cells. Scale bar is 10 μm. (b) Cell features captured by automated image analysis (Methods) from a single cell expressing mRuby-PCNA and p21-GFP. (c) Single-cell traces of p21-GFP levels aligned to S/G2; n=51 cells. Tracks are coloured according to p21-GFP intensity. Black circles represent mitosis. (d) Correlation between maximum G1 p21-GFP intensity and G1 length (Pearson's Correlation R=0.62** (P<0.01)). Three different 488 nm exposures are shown: Exp1, n=206 cells; Exp2, n=90; Exp3, n=52 (Methods). (e) Correlation in G1 p21-GFP levels between sister cells—G1 Daughter1 (G1D1) and G1 Daughter2 (G1D2; n=62, Pearson's Correlation R=0.81** (P<0.01)). Data points are coloured to represent correlation between G1 length in each daughter cell, calculated as the difference between the maximum and minimum G1 length divided by the sum of the sister G1 lengths, n=62. (f) Single-cell traces of p21-GFP levels aligned to mitotic exit; n=51 cells. Grey line marks 600 min time point used to define G1pm arrest. Red curves are cells that enter a G1pm arrest, blue curves are cells that enter S-phase (cycle). (g) Mean p21-GFP intensity in G2M separated by daughter cell fate: cycling, n=49 cells; single arrest, n=9; twin arrest, n=10. Significant differences are observed between arrested and cycling states using a two-sample t-test on log-transformed data. Error bar is s.d. *P<0.05, **P<0.01.CC BY · PubMed Central
Figure 2 p53 drives p21 heterogeneity in unperturbed conditions. (a) p21-GFP levels versus G1 length after siRNA treatment: control siRNA (blue), n=75 cells; p53 siRNA (yellow), n=81; or p21 siRNA (red), n=90. (b) Percentage of cells arresting in G1 for three siRNA treatments and for p21WT versus two p21KO clones. Number of cells is shown above each bar. Red bars represent cells that enter G1pm arrest, blue bars are cells that enter S-phase (cycle). (c) Single-cell traces of p21-GFP levels after 5 μM Nutlin-3 addition: S-phase on addition, yellow, n=8 cells; G1 on addition, blue, n=8. Time of mitosis is marked by black circles and time of S-phase entry is marked by blue circles on each single-cell trace. (d) Effect of rate of p21-GFP accumulation on G2 entry after Nutlin-3 addition to cells in S-phase. Black circles represent mitosis. Arrest, red, n=19 cells; Mitosis, blue, n=28. (e) CDK2 activity profiles aligned to mitosis for: control siRNA, n=51 cells; p21 siRNA, n=68 cells; and p53 siRNA, n=25 cells. Red curves represent CDK2low cells. Black circles represent time of S-phase entry. (f) Single-cell trace of CDK2 activity and p21-GFP levels in an unperturbed cell. Brown shading is G2. Grey shading shows a period in G1 where CDK2 activity is increasing despite expression of p21-GFP. Traces aligned to S-phase entry at t=0 min. p21-GFP levels are shown in green and CDK2 activity is shown in red. (g) Single-cell trace of CDK2 activity and p21-GFP levels in an unperturbed cell arrested in G1. p21-GFP levels are shown in green and CDK2 activity is shown in red. Note: different scale for p21-GFP y-axis compared to (f).
Figure 2 p53 drives p21 heterogeneity in unperturbed conditions. (a) p21-GFP levels versus G1 length after siRNA treatment: control siRNA (blue), n=75 cells; p53 siRNA (yellow), n=81; or p21 siRNA (red), n=90. (b) Percentage of cells arresting in G1 for three siRNA treatments and for p21WT versus two p21KO clones. Number of cells is shown above each bar. Red bars represent cells that enter G1pm arrest, blue bars are cells that enter S-phase (cycle). (c) Single-cell traces of p21-GFP levels after 5 μM Nutlin-3 addition: S-phase on addition, yellow, n=8 cells; G1 on addition, blue, n=8. Time of mitosis is marked by black circles and time of S-phase entry is marked by blue circles on each single-cell trace. (d) Effect of rate of p21-GFP accumulation on G2 entry after Nutlin-3 addition to cells in S-phase. Black circles represent mitosis. Arrest, red, n=19 cells; Mitosis, blue, n=28. (e) CDK2 activity profiles aligned to mitosis for: control siRNA, n=51 cells; p21 siRNA, n=68 cells; and p53 siRNA, n=25 cells. Red curves represent CDK2low cells. Black circles represent time of S-phase entry. (f) Single-cell trace of CDK2 activity and p21-GFP levels in an unperturbed cell. Brown shading is G2. Grey shading shows a period in G1 where CDK2 activity is increasing despite expression of p21-GFP. Traces aligned to S-phase entry at t=0 min. p21-GFP levels are shown in green and CDK2 activity is shown in red. (g) Single-cell trace of CDK2 activity and p21-GFP levels in an unperturbed cell arrested in G1. p21-GFP levels are shown in green and CDK2 activity is shown in red. Note: different scale for p21-GFP y-axis compared to (f).CC BY · PubMed Central
Figure 3 Basal p21 expression correlates with the presence of DNA damage foci. (a) Images of hTert-RPE1 mRuby-PCNA p21-GFP cells fixed and stained for γH2AX. Magnified regions of each image are also shown. p21-GFP is green, γH2AX is red in merged images. Scale bars are 10 μm. (b) Quantification of p21-GFP nuclear fluorescence in interphase (excluding S-phase) cells with or without γH2AX nuclear foci. With foci, n=2086 cells; without foci, n=12476. (c) Quantification of number of γH2AX foci per nucleus after separation of cells based on a high or low p21-GFP nuclear fluorescence (high p21>30 a.u.). High p21-GFP, n=3896 cells; low p21-GFP, n=11049. (d) Fates of sister cells pairs (D1 and D2) with regards to 53BP1 focus appearance. 142 daughter pairs were analysed. (e) Correlation between the time of 53BP1 focus appearance in sister cells. 45 sister pairs are shown. Note: 14 sister pairs are clustered at time 0,0 min and are not visible as separate values. Pearson's Correlation R=0.39* (P<0.05). (f) Histogram of G1 length separated by the presence or absence of a 53BP1-GFP focus. The difference between the two populations is significant (unpaired student's t-test P=0.0003). 118 cells were scored manually.
Figure 3 Basal p21 expression correlates with the presence of DNA damage foci. (a) Images of hTert-RPE1 mRuby-PCNA p21-GFP cells fixed and stained for γH2AX. Magnified regions of each image are also shown. p21-GFP is green, γH2AX is red in merged images. Scale bars are 10 μm. (b) Quantification of p21-GFP nuclear fluorescence in interphase (excluding S-phase) cells with or without γH2AX nuclear foci. With foci, n=2086 cells; without foci, n=12476. (c) Quantification of number of γH2AX foci per nucleus after separation of cells based on a high or low p21-GFP nuclear fluorescence (high p21>30 a.u.). High p21-GFP, n=3896 cells; low p21-GFP, n=11049. (d) Fates of sister cells pairs (D1 and D2) with regards to 53BP1 focus appearance. 142 daughter pairs were analysed. (e) Correlation between the time of 53BP1 focus appearance in sister cells. 45 sister pairs are shown. Note: 14 sister pairs are clustered at time 0,0 min and are not visible as separate values. Pearson's Correlation R=0.39* (P<0.05). (f) Histogram of G1 length separated by the presence or absence of a 53BP1-GFP focus. The difference between the two populations is significant (unpaired student's t-test P=0.0003). 118 cells were scored manually.CC BY · PubMed Central
Figure 4 Impaired DNA replication can induce p21 expression. (a) Number of γH2AX foci per nucleus in cells treated with DMSO or aphidicolin for 24 h. DMSO, n=1527 cells; 0.3 μM Aph, n=775; 0.6 μM Aph, n=745. (b) Single-cell traces of p21-GFP expression after treatment of asynchronous cells with: DMSO, n=38; 0.3 μM aphidicolin, n=32; or 0.5 μM ATRi, n=40. All traces are aligned to S-phase exit. Black circles represent mitosis. Blue curves represent cells that enter S-phase, red curves represent cells that arrest in G1 and yellow curves represent cells that arrest in G2. (c) Number of γH2AX foci per nucleus in cells treated with DMSO or ATRi for 24 h. n=1527, DMSO; n=1420, 0.5 μM ATRi; n=1467, 1 μM ATRi. (d) CDK2 activity profiles in cells treated with 0.3 μM aphidicolin and: n=34, DMSO; n=32, p53; and n=42, p21 siRNA, aligned to S/G2. Black circles represent mitosis. Blue curves represent cells that enter S-phase, red curves represent cells that arrest in G1 and yellow curves represent cells that arrest in G2.
Figure 4 Impaired DNA replication can induce p21 expression. (a) Number of γH2AX foci per nucleus in cells treated with DMSO or aphidicolin for 24 h. DMSO, n=1527 cells; 0.3 μM Aph, n=775; 0.6 μM Aph, n=745. (b) Single-cell traces of p21-GFP expression after treatment of asynchronous cells with: DMSO, n=38; 0.3 μM aphidicolin, n=32; or 0.5 μM ATRi, n=40. All traces are aligned to S-phase exit. Black circles represent mitosis. Blue curves represent cells that enter S-phase, red curves represent cells that arrest in G1 and yellow curves represent cells that arrest in G2. (c) Number of γH2AX foci per nucleus in cells treated with DMSO or ATRi for 24 h. n=1527, DMSO; n=1420, 0.5 μM ATRi; n=1467, 1 μM ATRi. (d) CDK2 activity profiles in cells treated with 0.3 μM aphidicolin and: n=34, DMSO; n=32, p53; and n=42, p21 siRNA, aligned to S/G2. Black circles represent mitosis. Blue curves represent cells that enter S-phase, red curves represent cells that arrest in G1 and yellow curves represent cells that arrest in G2.CC BY · PubMed Central
Figure 5 Skp2- and Cdt2-dependent pathways degrade p21 with different rates and timings. (a) Single-cell traces, coloured by p21-GFP intensity in G1, aligned to the G1/S transition. Four siRNA treatments are shown: n=65 cells, control; n=81, Skp2; n=37, Cdt2; n=25, Skp2 and Cdt2 co-depletion. Black circles represent mitosis. Note: only cells entering S-phase are shown. (b) Graph shows correlation between p21-GFP intensity and G1 length for each siRNA condition shown in (a): n=50 cells, control; n=54, Skp2; n=9, Cdt2; n=14, Skp2 and Cdt2 co-depletion. (c) Graph shows average p21-GFP nuclear level across FOV for four different siRNA treatments. Four FOVs are shown for control siRNA cells and two FOVs are shown for the other treatments, each curve is one FOV. Control siRNA is shown in blue, Skp2 siRNA is shown in green, Cdt2 siRNA is shown in yellow and double Skp2 and Cdt2 depletion is shown in red.
Figure 5 Skp2- and Cdt2-dependent pathways degrade p21 with different rates and timings. (a) Single-cell traces, coloured by p21-GFP intensity in G1, aligned to the G1/S transition. Four siRNA treatments are shown: n=65 cells, control; n=81, Skp2; n=37, Cdt2; n=25, Skp2 and Cdt2 co-depletion. Black circles represent mitosis. Note: only cells entering S-phase are shown. (b) Graph shows correlation between p21-GFP intensity and G1 length for each siRNA condition shown in (a): n=50 cells, control; n=54, Skp2; n=9, Cdt2; n=14, Skp2 and Cdt2 co-depletion. (c) Graph shows average p21-GFP nuclear level across FOV for four different siRNA treatments. Four FOVs are shown for control siRNA cells and two FOVs are shown for the other treatments, each curve is one FOV. Control siRNA is shown in blue, Skp2 siRNA is shown in green, Cdt2 siRNA is shown in yellow and double Skp2 and Cdt2 depletion is shown in red.CC BY · PubMed Central
Figure 6 Two double-negative feedback loops control p21 degradation. (a) Influence diagram of the p21 regulatory network. p21 is engaged in two mutually inhibitory motifs with CDK2:Cyclin and aRCs. CDK2 activity primes replication complexes (pRC) for PCNA loading, which facilitates S-phase entry and DNA synthesis by aRCs. The latter can cause DNA damage and p53 expression, promoting p21 synthesis and DNA repair. (b) Stochastic simulation of p21 (top), and total CDK2:Cyclin and aRCs (bottom), relative to the G1/S transition; n=10. Grey shaded regions indicate S-phase. (c) Relative level of p21, p53 and DNA damage in four simulated cells. Grey shaded regions indicate S-phase. Note p21 absence in S-phase even in cells that suffer damage (for example, lower right). (d) Stable (solid) and unstable (dashed) steady states of p21 with respect to the total level of CDK2:Cyclin for increasing DNA damage. The G1/S transition is indicated for intermediate levels of damage. (e) Stochastic simulation of p21 (upper panels) and aRCs (lower panels) in Skp2-depleted (left) and Cdt2-depleted (right) cells; n=10.
Figure 6 Two double-negative feedback loops control p21 degradation. (a) Influence diagram of the p21 regulatory network. p21 is engaged in two mutually inhibitory motifs with CDK2:Cyclin and aRCs. CDK2 activity primes replication complexes (pRC) for PCNA loading, which facilitates S-phase entry and DNA synthesis by aRCs. The latter can cause DNA damage and p53 expression, promoting p21 synthesis and DNA repair. (b) Stochastic simulation of p21 (top), and total CDK2:Cyclin and aRCs (bottom), relative to the G1/S transition; n=10. Grey shaded regions indicate S-phase. (c) Relative level of p21, p53 and DNA damage in four simulated cells. Grey shaded regions indicate S-phase. Note p21 absence in S-phase even in cells that suffer damage (for example, lower right). (d) Stable (solid) and unstable (dashed) steady states of p21 with respect to the total level of CDK2:Cyclin for increasing DNA damage. The G1/S transition is indicated for intermediate levels of damage. (e) Stochastic simulation of p21 (upper panels) and aRCs (lower panels) in Skp2-depleted (left) and Cdt2-depleted (right) cells; n=10.CC BY · PubMed Central
Figure 7 Arrest in response to serum starvation is not p21-dependent. (a) Single-cell traces of p21-GFP levels aligned to mitotic exit (serum was withdrawn in the previous cycle); n=29 cells. Grey line marks 600 min time point used to define G1pm arrest. Red curves represent cells entering G1pm arrest, blue curves represent cells that enter S-phase. (b) Graph showing the percentage of cells arresting in G1 in three different mRuby-PCNA hTert-RPE1 cell lines (WT and two p21KO clones) after serum withdrawal for 24 h. Mean and s.d. of two independent FACS experiments are shown. (c) Model for how p21 propagates information on DNA damage in the mother cell to influence the proliferation-quiescence decision in daughter cells. At intermediate levels of p21 (purple curve) cells still cycle, albeit with a G1 delay that is p53-dependent but p21-independent.
Figure 7 Arrest in response to serum starvation is not p21-dependent. (a) Single-cell traces of p21-GFP levels aligned to mitotic exit (serum was withdrawn in the previous cycle); n=29 cells. Grey line marks 600 min time point used to define G1pm arrest. Red curves represent cells entering G1pm arrest, blue curves represent cells that enter S-phase. (b) Graph showing the percentage of cells arresting in G1 in three different mRuby-PCNA hTert-RPE1 cell lines (WT and two p21KO clones) after serum withdrawal for 24 h. Mean and s.d. of two independent FACS experiments are shown. (c) Model for how p21 propagates information on DNA damage in the mother cell to influence the proliferation-quiescence decision in daughter cells. At intermediate levels of p21 (purple curve) cells still cycle, albeit with a G1 delay that is p53-dependent but p21-independent.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 2

  1. Magnusson, K. E. G. & Joakim, J. in 2012 9th IEEE International Symposium on Biomedical Imaging (ISBI) (2012).
  2. Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438–449 (2008). · DOI · Paper page

Cited by

Metadata

Authors
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C.
Affiliations
  • Institute of Cancer Research (GB)
  • University of Oxford (GB)
  • Biotechnologisches Zentrum (DE)
Corresponding author
  • Barr, Alexis R.
  • Bakal, Chris
Venue
Nature Communications
Published
2017-03-20
Volume
8
Issue
1
Pages
14728-14728
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2603712266
Cited by
403
References
73
Citations by year
2026: 27 · 2025: 52 · 2024: 51 · 2023: 35 · 2022: 49 · 2021: 59 · 2020: 54 · 2019: 30 · 2018: 29 · 2017: 16
FWCI
15.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (MA 5831/11)
  • Biotechnology and Biological Sciences Research Council (BB/M00354X/1)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
DNA damage, S phase, p21, p53, G1 cell cycle arrest, cell cycle regulation, CDK inhibition, ubiquitin ligase, bistable switch, genome stability, single-cell tracking, mathematical modeling
MeSH terms
Cell Division, Cell Line, DNA Damage, Humans, Tumor Suppressor Protein p53, G1 Phase, S Phase, Microscopy, Confocal, Genomic Instability, Cell Proliferation, Green Fluorescent Proteins, Cyclin-Dependent Kinase Inhibitor p21, Gene Knockout Techniques, Cell Tracking, Cell Cycle Checkpoints

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.